ES2195543T3 - Derivados de 5'-deoxicitidina. - Google Patents
Derivados de 5'-deoxicitidina.Info
- Publication number
- ES2195543T3 ES2195543T3 ES99907492T ES99907492T ES2195543T3 ES 2195543 T3 ES2195543 T3 ES 2195543T3 ES 99907492 T ES99907492 T ES 99907492T ES 99907492 T ES99907492 T ES 99907492T ES 2195543 T3 ES2195543 T3 ES 2195543T3
- Authority
- ES
- Spain
- Prior art keywords
- lower alkyl
- alkyl
- cycloalkyl
- groups
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/167—Purine radicals with ribosyl as the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Un compuesto representado por la fórmula general (I) en el que R1 es cada uno independientemente hidrógeno o un grupo fácilmente hidrolizable en condiciones fisiológicas; R2 es - (CH2)n - cicloalquilo [en donde cicloalquilo consiste en de 3 a 5 átomos de carbono, n es un entero de 0 a 4], heteroaril - (alquilo - inferior), (alcoxi - inferior) - (alquilo - inferior), ariloxi - (alquilo - inferior), aralquiloxi - (alquilo - inferior), (alquiltio - inferior) - (alquilo - inferior), ariltio - (alquilo - inferior), aralquiltio - (alquilo - inferior), oxo - (alquilo - inferior), acilamino - (alquilo - inferior), amino cíclico - (alquilo - inferior), (amino 2 - oxocíclico) - (alquilo - inferior), en donde la cadena alquileno puede estar sustituida adicionalmente con uno o dos grupos alquilo - inferior y R3 es yodo, un grupo vinilo o etinilo [los cuales grupos pueden estar sustituidos con átomos de halógeno, alquilo C1-4, cicloalquilo, aralquilo, o un anillo aromático que puede presentar uno o másheteroátomos].
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98102080 | 1998-02-06 | ||
EP98108321 | 1998-05-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2195543T3 true ES2195543T3 (es) | 2003-12-01 |
Family
ID=26149007
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES99907492T Expired - Lifetime ES2195543T3 (es) | 1998-02-06 | 1999-02-03 | Derivados de 5'-deoxicitidina. |
Country Status (19)
Country | Link |
---|---|
US (1) | US6005098A (es) |
EP (1) | EP1060183B1 (es) |
JP (2) | JP3625276B2 (es) |
KR (1) | KR100381516B1 (es) |
CN (1) | CN1260240C (es) |
AR (1) | AR014539A1 (es) |
AT (1) | ATE238335T1 (es) |
AU (1) | AU757136B2 (es) |
BR (1) | BR9907672A (es) |
CA (1) | CA2318848C (es) |
CO (1) | CO5070642A1 (es) |
DE (1) | DE69907161T2 (es) |
DK (1) | DK1060183T3 (es) |
ES (1) | ES2195543T3 (es) |
MA (1) | MA26606A1 (es) |
PE (1) | PE20000244A1 (es) |
PT (1) | PT1060183E (es) |
TR (1) | TR200002297T2 (es) |
WO (1) | WO1999040099A1 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030119724A1 (en) * | 1995-11-22 | 2003-06-26 | Ts`O Paul O.P. | Ligands to enhance cellular uptake of biomolecules |
EP0882734B1 (en) * | 1997-06-02 | 2009-08-26 | F. Hoffmann-La Roche Ag | 5'-Deoxy-cytidine derivatives |
DE60013957T2 (de) | 1999-05-26 | 2006-02-23 | F. Hoffmann-La Roche Ag | Verfahren zur Herstellung von Vinylpyrimidinderivaten |
KR100631754B1 (ko) * | 2000-08-09 | 2006-10-09 | 주식회사 코오롱 | N-알킬옥시카르보닐-5-플루오로사이토신 유도체 및 그의제조방법 |
AU2002217980A1 (en) | 2000-12-01 | 2002-06-11 | Cell Works Inc. | Conjugates of glycosylated/galactosylated peptide |
CN100383128C (zh) * | 2004-02-23 | 2008-04-23 | 上海迪赛诺医药发展有限公司 | N4-氧羰基胞嘧啶衍生物及制备方法与应用 |
DE112006000873T5 (de) * | 2005-04-12 | 2008-03-06 | Elan Pharma International Ltd. | Zusammensetzungen mit modifizierter Freisetzung, umfassend ein Fluorcytidin-Derivate zur Behandlung von Krebs |
JP6866113B2 (ja) * | 2016-11-01 | 2021-04-28 | 日本化薬株式会社 | カペシタビンを有効成分とする医薬製剤 |
JP6792418B2 (ja) * | 2016-11-08 | 2020-11-25 | 日本化薬株式会社 | カペシタビンを有効成分とする医薬製剤の製造方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1561290A (en) * | 1975-10-16 | 1980-02-20 | Nyegaard & Co As | Pyrimid - 2 - ones |
JPS54129131A (en) * | 1978-03-27 | 1979-10-06 | Taiho Pharmaceutical Co Ltd | Antiimalignant tumor agent composition |
GB2016921B (en) * | 1978-03-27 | 1982-08-18 | Taiho Pharmaceutical Co Ltd | Anti cancer compositions containing uracil derivatives |
US4328229A (en) * | 1978-03-29 | 1982-05-04 | Taiho Pharmaceutical Company Limited | Anti-cancer composition for delivering 5-fluorouracil to cancer tissues |
CA1327358C (en) * | 1987-11-17 | 1994-03-01 | Morio Fujiu | Fluoro cytidine derivatives |
DK0539442T3 (da) * | 1990-07-19 | 1998-09-07 | Wellcome Found | Enzyminaktivatorer |
GB9020930D0 (en) * | 1990-09-26 | 1990-11-07 | Wellcome Found | Pharmaceutical combinations |
EP0543015B1 (en) * | 1991-05-27 | 1998-11-11 | Taiho Pharmaceutical Co., Ltd. | Composition, method and kit for potentiating antitumor activity and for curing tumor |
AU671491B2 (en) * | 1992-12-18 | 1996-08-29 | F. Hoffmann-La Roche Ag | N-oxycarbonyl substituted 5'-deoxy-5-fluorcytidines |
TW254946B (es) * | 1992-12-18 | 1995-08-21 | Hoffmann La Roche | |
EP0882734B1 (en) * | 1997-06-02 | 2009-08-26 | F. Hoffmann-La Roche Ag | 5'-Deoxy-cytidine derivatives |
-
1999
- 1999-01-20 US US09/234,200 patent/US6005098A/en not_active Expired - Fee Related
- 1999-02-02 PE PE1999000082A patent/PE20000244A1/es not_active Application Discontinuation
- 1999-02-03 PT PT99907492T patent/PT1060183E/pt unknown
- 1999-02-03 WO PCT/EP1999/000710 patent/WO1999040099A1/en active IP Right Grant
- 1999-02-03 DE DE69907161T patent/DE69907161T2/de not_active Expired - Fee Related
- 1999-02-03 JP JP2000530527A patent/JP3625276B2/ja not_active Expired - Fee Related
- 1999-02-03 TR TR2000/02297T patent/TR200002297T2/xx unknown
- 1999-02-03 AT AT99907492T patent/ATE238335T1/de not_active IP Right Cessation
- 1999-02-03 BR BR9907672-1A patent/BR9907672A/pt not_active Application Discontinuation
- 1999-02-03 KR KR10-2000-7008488A patent/KR100381516B1/ko not_active IP Right Cessation
- 1999-02-03 CA CA002318848A patent/CA2318848C/en not_active Expired - Fee Related
- 1999-02-03 DK DK99907492T patent/DK1060183T3/da active
- 1999-02-03 CN CNB998027588A patent/CN1260240C/zh not_active Expired - Fee Related
- 1999-02-03 AU AU27227/99A patent/AU757136B2/en not_active Ceased
- 1999-02-03 ES ES99907492T patent/ES2195543T3/es not_active Expired - Lifetime
- 1999-02-03 EP EP99907492A patent/EP1060183B1/en not_active Expired - Lifetime
- 1999-02-04 AR ARP990100469A patent/AR014539A1/es unknown
- 1999-02-04 CO CO99006410A patent/CO5070642A1/es unknown
- 1999-02-05 MA MA25456A patent/MA26606A1/fr unknown
-
2004
- 2004-07-06 JP JP2004199438A patent/JP2004339230A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2318848A1 (en) | 1999-08-12 |
DE69907161T2 (de) | 2004-02-05 |
AR014539A1 (es) | 2001-02-28 |
JP2004339230A (ja) | 2004-12-02 |
DE69907161D1 (de) | 2003-05-28 |
JP2002502857A (ja) | 2002-01-29 |
CA2318848C (en) | 2008-09-02 |
MA26606A1 (fr) | 2004-12-20 |
KR100381516B1 (ko) | 2003-04-23 |
US6005098A (en) | 1999-12-21 |
EP1060183B1 (en) | 2003-04-23 |
AU2722799A (en) | 1999-08-23 |
CN1290269A (zh) | 2001-04-04 |
WO1999040099A1 (en) | 1999-08-12 |
DK1060183T3 (da) | 2003-08-11 |
KR20010072543A (ko) | 2001-07-31 |
EP1060183A1 (en) | 2000-12-20 |
CO5070642A1 (es) | 2001-08-28 |
ATE238335T1 (de) | 2003-05-15 |
PT1060183E (pt) | 2003-08-29 |
CN1260240C (zh) | 2006-06-21 |
TR200002297T2 (tr) | 2000-12-21 |
JP3625276B2 (ja) | 2005-03-02 |
PE20000244A1 (es) | 2000-04-10 |
BR9907672A (pt) | 2000-11-28 |
AU757136B2 (en) | 2003-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3852266D1 (de) | Azaspirane mit immunmodulierender Wirkung. | |
DK0378518T3 (da) | Adenosinderivater med farmaceutisk aktivitet som antihypertensiva | |
LU91196I2 (fr) | Picoxystrobin et ses dérivlés pharmaceutiquement acceptables(ACANTO). | |
NO905306D0 (no) | Spirocykliske forbindelser som inneholder nitrogen. | |
DE3781716D1 (de) | Mittel zur ortsspezifischen alkylierung. | |
ES2093672T3 (es) | Composicion blanqueante liquida acuosa. | |
AU591780B2 (en) | Benzo{b}thiophene- and benzo{b}furancarboxamide derivatives their preparation, and pharmaceutical compositions containing them | |
FI832092L (fi) | 1-aryloxi-2,3,4,5-tetrahydro-3-bensazepiner, foerfarande foer framstaellning av dem och anvaendning av dem som laekemedel | |
EA200200098A1 (ru) | Ароматические сложные эфиры для маркировки или мечения нефтепродуктов | |
ES2179005T3 (es) | Compuesto de cromeno. | |
ES2195543T3 (es) | Derivados de 5'-deoxicitidina. | |
DK0518558T3 (da) | 1-methylcarbapenemderivater, deres fremstilling og deres anvendelse som antibiotika | |
KR900000351A (ko) | 1-아릴-나프토일아민 및 그의 제조방법 | |
ATE239722T1 (de) | Benzofurylpiperazine als serotonin-agonisten | |
KR910009670A (ko) | 이미다졸 살균제 | |
SE8600046L (sv) | Anvendning av en esterforening som temporer baktericid och produkt innehallande esterforeningen | |
DK415789A (da) | Tetracykliske antidepressive midler | |
DK0601191T3 (da) | Hidtil ukendt tetracyklisk forbindelse | |
ES2059595T3 (es) | Beta-carbonil-carboxiamidas de 1,3-tiazolidinas. | |
DE3661198D1 (en) | Phosphate ester derivatives, and their use as anti-cancer agents | |
FI891087A0 (fi) | Nya kefemfoereningar och foerfarande foer deras framstaellning. | |
AR247737A1 (es) | Un procedimiento para la fabricacion de compuestos. | |
EA200300029A1 (ru) | Новые соединения карбамат и тиокарбамат подофиллотоксина, способ их получения и содержащие их фармацевтические композиции | |
ES8301931A1 (es) | Un procedimiento para la preparacion de nuevos imidazoles. | |
KR910006310A (ko) | 신규한 나프탈렌 및 테트라히드로 나프탈렌 치환된 겜-디포스포네이트 유도체 |